Literature DB >> 3930272

Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes.

W E Mercer, R Baserga.   

Abstract

We have investigated the role of the cellular p53 protein in the induction of growth in size and cell DNA replication in human peripheral blood lymphocytes (PBL) and in monocyte/macrophage-depleted lymphocyte (MDL) cultures stimulated with phytohemagglutinin (PHA). Our results show that in human lymphocytes exposed to PHA, the induction of p53 protein synthesis and accumulation correlates with the extent of cellular DNA replication, rather than with growth in size. Moreover, the induction of p53 is dependent on the presence of the T-cell mitogen, Interleukin-2. A monoclonal antibody to Interleukin-2 receptors (anti-Tac) inhibits PHA-stimulated cellular DNA synthesis, and this inhibition is correlated with a reduction in the percentage of p53-positive cells. We conclude from this work that the p53 protein is a cell cycle-dependent gene whose expression can be regulated by different mitogens in different cell types.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930272     DOI: 10.1016/0014-4827(85)90233-2

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  22 in total

1.  Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.

Authors:  D Lin; M T Shields; S J Ullrich; E Appella; W E Mercer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  p53 expression in lymphatic malignancies.

Authors:  Y Soini; P Pääkkö; M Alavaikko; K Vähäkangas
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

Review 3.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Coding sequence and growth regulation of the human vimentin gene.

Authors:  S Ferrari; R Battini; L Kaczmarek; S Rittling; B Calabretta; J K de Riel; V Philiponis; J F Wei; R Baserga
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

5.  Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation.

Authors:  B Rovinski; D Munroe; J Peacock; M Mowat; A Bernstein; S Benchimol
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

6.  Expression of p53 product in Chinese human bladder carcinoma.

Authors:  D W Ye; J F Zheng; S X Qian; Y J Ma
Journal:  Urol Res       Date:  1993-05

7.  Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts.

Authors:  P Muganda; O Mendoza; J Hernandez; Q Qian
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  p53 alterations in human squamous cell carcinomas and carcinoma cell lines.

Authors:  J Caamano; S Y Zhang; E A Rosvold; B Bauer; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

9.  Low p53 protein expression in salivary gland tumours compared with lung carcinomas.

Authors:  Y Soini; D Kamel; K Nuorva; D P Lane; K Vähäkangas; P Pääkkö
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells.

Authors:  Marc R Theoret; Cyrille J Cohen; Azam V Nahvi; Lien T Ngo; Kimberly B Suri; Daniel J Powell; Mark E Dudley; Richard A Morgan; Steven A Rosenberg
Journal:  Hum Gene Ther       Date:  2008-11       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.